90 Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors

Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, Mélanie Desaulniers, Kim Magaly Pabst, Ilektra Antonia Mavroeidi, […]

2025-09-04T19:02:23+00:0024, Jul 2025|Publications|

Early image acquisition 68Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinoma 

D Ufton, J Heilinger, H Weis, T Fischer, K Schomäcker, C Bruns, G Dieplinger, H […]

2025-10-15T16:40:43+00:0016, Jul 2025|Publications|

Current State of FAP Targeting Radioligands in Oncology

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
SOFIE Educational Webinar Series
June 18, 2025 – 

2025-11-03T16:12:25+00:0018, Jun 2025|Webinars|

Focus on FAPI Newsletter – Q2 2025

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

2025-12-03T20:10:27+00:009, Jun 2025|Newsletter|

Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis

Yuriko Mori, Katharina Tamburini, Emil Novruzov, Dominik Schmitt, Eleni Mavriopoulou, Sven H Loosen, Christoph Roderburg, […]

2025-10-15T16:40:43+00:009, Jun 2025|Publications|

Comparison of [99mTc]Tc-FAPI SPECT/CT and [18F]FDG PET/CT as predictive biomarkers for immunotherapy response in gastrointestinal cancer

Yu Zhang, Hong Chen, Dajia Lin, Zhiyi Lin, Jiyun Shi, Hannan Gao, Chenshen Huang, Fangqing […]

2025-10-15T16:39:28+00:0014, May 2025|Publications|

SOFIE Biosciences opens PET Manufacturing Facility, expanding service in Illinois, Missouri, and Indiana

Dulles, VA  (March 31, 2025) – Today, SOFIE Biosciences, a leader in radiopharmaceuticals, […]

2025-10-13T13:30:27+00:001, Apr 2025|News|

Amyloid Biomarker Imaging and FDG in the Era of an Approved Anti Amyloid Therapy

Watch Webinar

2025-11-03T16:19:51+00:0028, Mar 2025|Webinars|

Focus on FAPI Newsletter – Q4 2025

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI […]

2025-12-03T20:10:18+00:0013, Mar 2025|Newsletter|
Go to Top